September 30, 2009 - The founding members of the American Society of Clinical Radiation Oncology (ASCRO) announced its addition as a new professional non-profit organization primarily dedicated to acquiring a "Provider Status" for clinical radiation oncology physicists.
"ASCRO believes that the quality of patient care will be significantly enhanced when clinical radiation oncology physicists are given Provider Status. Such a status will allow them to make professional decisions based solely on the best interest of cancer patients," said Nabil Adnani, Ph.D., ASCRO's president and founding member. "By joining ASCRO in large numbers, clinical radiation oncology physicists will ensure, and for the first time in history, their true place as medical professionals," Dr. Adnani went on to say.
"Finally, a long overdue society is born. Clinical Radiation Oncology Physicists now have an organization they can call their own," said Ivan Brezovich, Ph.D., ASCRO's chairman and founding member.
ASCRO will work with existing organizations and will seek advice from more established professional societies such as the American Association of Physicists in Medicine (AAPM) and the American Society for Therapeutic Radiation Oncology (ASTRO) in its efforts to obtain a "Provider Status" for its members.

ASCRO was founded in February 2009, ASCRO obtained its non-profit status in April 2009.

For more information: www.ascro.org


Related Content

News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Radiology Imaging

Jan. 21, 2026 — Cathpax, a spin-off of the Lemer Pax group that designs, develops and commercializes team-wide, full ...

Time January 22, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
News | Radiopharmaceuticals and Tracers

Dec. 11, 2025 — Telix Pharmaceuticals Ltd. has announced a strategic clinical collaboration with Varian, a Siemens ...

Time December 11, 2025
arrow
News | FDA

Dec. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT, has announced ...

Time December 04, 2025
arrow
News | Interventional Radiology

Nov. 12, 2025 — On Nov. 11, Huntsman Cancer Institute at the University of Utah (the U) opened its first specialized ...

Time November 13, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
News | Radiopharmaceuticals and Tracers

Nov. 11, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining ...

Time November 12, 2025
arrow
News | Prostate Cancer

Nov. 10, 2025 — Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a ...

Time November 11, 2025
arrow
Subscribe Now